About
Evogene is not a chemical producer and does not pretend to be. It is an Israeli computational chemistry company that uses AI and computational biology to discover new active ingredients — a discovery-and-development model rather than a bulk supply one. Listed on both NASDAQ and the Tel Aviv Stock Exchange (EVGN), it was founded in 2002 in Rehovot. What the company offers is access to platforms rather than products: ChemPass AI for generative small-molecule design, MicroBoost AI, agricultural biologicals through Lavie Bio, and crop protection molecules. Its operating divisions — Lavie Bio, AgPlenus, Canonic and Biomica — address different corners of the same problem, finding molecules that work before anyone has synthesized them at scale. The right buyer for this kind of company is not placing a purchase order. It is a business seeking new actives, improved formulations or co-development, and the engagement runs through R&D and licensing agreements instead. Evogene collaborates with major global chemical and pharmaceutical partners on exactly that basis. An initial conversation is most productive when it describes the target profile — the crop, the pest, the mechanism of action — and the stage the partner is at, since the terms differ substantially between early discovery and closer-to-market work.
Also known as: Evogene Ltd, Evogene
Company Facts
- Founded
- 2002
- Headquarters
- Rehovot, Israel
- Listed
- NASDAQ (EVGN) & TASE
- Industry
- Computational Chemistry & AgTech
- Business Type
- Technology & R&D Company
- Employees
- 100+
- Annual Revenue
- US$ 10M - 50M
- Key Platforms
- ChemPass AI, MicroBoost AI
- Focus Areas
- Crop protection, seed traits, ag-biologicals, human health
- Business Model
- Discovery, licensing & partnerships
Frequently Asked Questions
What does Evogene do?+
Evogene uses artificial intelligence and computational biology to discover and develop novel molecules and biological products, primarily for crop protection, seed traits and life sciences.
Is Evogene publicly traded?+
Yes. Evogene Ltd is listed on the NASDAQ Global Market under the ticker EVGN and on the Tel Aviv Stock Exchange.
What are Evogene's technology platforms?+
Evogene's key platforms include ChemPass AI for small-molecule discovery and MicroBoost AI for microbiome-based product discovery.
Where is Evogene located?+
Evogene is headquartered in Rehovot, Israel.
How does Evogene make money?+
Evogene develops products and technologies that it licenses and commercializes through partnerships with global life-science and agricultural corporations.
Top Products
ChemPass AI Platform
AI-driven computational platform for small-molecule discovery, identifying novel chemistries for crop protection and pharma.
MOQ: Licensing
MicroBoost AI Platform
Computational platform for discovering microbiome-based products for agriculture and health.
MOQ: Licensing
Ag-Biologicals
Biological crop-input products discovered via Evogene's computational platforms.
MOQ: Partnership
Crop Protection Molecules
Novel herbicide, insecticide and fungicide candidates developed for licensing to agrochemical companies.
MOQ: Licensing